Gastroenterology Research and Practice / 2018 / Article / Tab 2

Research Article

A New Scoring System to Predict Poor Clinical Outcomes in Acute Nonvariceal Upper Gastrointestinal Bleeding Patients with High-Risk Stigmata

Table 2

Univariate and multivariate analysis between rebleeding case and no rebleeding case.

Rebleeding case ()No rebleeding case () value value

Age (>60), number (%)17 (44.7%)66 (38.6%)0.485
Sex (male), number (%)30 (78.9%)143 (83.6%)0.491
HR (>100 beats/min), number (%)12 (31.6%)27 (15.8%)0.027
SBP (<90 mmHg), number (%)5 (13.2%)6 (3.5%)0.0250.016
Alcohol (yes), number (%)9 (23.7%)31 (18.1%)0.433
Smoke (yes), number (%)14 (36.8%)50 (29.2%)0.359
UGIB history (yes), number (%)8 (21.1%)40 (23.4%)0.757
Multiple therapies, number (%)3 (7.9%)34 (19.9%)0.0920.015
HR/SBP, mean (SD)0.89 (0.38)0.73 (0.21)0.023
HB, mean (SD), g/L86.82 (26.94)105.25 (26.47)0.0010.002
BUN, mean (SD), mmol/L13.53 (6.92)10.55 (5.77)0.0040.115
Creatinine, mean (SD), μmol/L103.55 (46.49)82.08 (49.39)0.0010.004
Glucose, mean (SD), mmol/L8.09 (3.44)7.93 (3.97)0.188
ALT, mean (SD), U/L41.13 (70.54)28.71 (22.28)0.268
AST, mean (SD), U/L42.37 (84.1)24.73 (26.97)0.693

HR: heart rate; SBP: systolic blood pressure; HB: hemoglobin; BUN: blood urea nitrogen; AST: aspartate transaminase; ALT: alanine aminotransferase; multiple therapies was defined as submucosal epinephrine injection plus thermal or mechanical hemostasis.